Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug shrinks tumors in some Hard-to-Treat lung cancers

NCT ID NCT04644237

Completed Disease control Sponsor: Daiichi Sankyo Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a drug called trastuzumab deruxtecan in 152 people with advanced non-small cell lung cancer that has a specific genetic change (HER2 mutation) and has stopped responding to standard chemotherapy. The drug is given by IV every three weeks and aims to shrink tumors. The main goal was to see how many patients had their tumors shrink significantly.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

trastuzumab deruxtecan (a targeted antibody-drug combination)

What this could lead to

If successful, this could provide a new treatment option for people with a specific genetic subtype of advanced lung cancer that has stopped responding to standard chemotherapy.

What could go wrong

This is a mid-stage trial with only 152 participants, so results may not apply to all patients. The drug can cause serious side effects like lung inflammation, and it is not a cure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL-CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL-CELL LUNG CANCER

Contacts and locations

Locations

  • AdventHealth Orlando

    Orlando, Florida, 32803, United States

  • Aichi Cancer Center Hospital

    Chikusa, 464-8681, Japan

  • Asan Medical Center

    Seoul, 3080, South Korea

  • Assistance Publique Hopitaux de Marseille AP-HM, Hopital NORD

    Marseille, 13015, France

  • Azienda Ospedaliero-Universitaria San Luigi Gonzaga

    Orbassano, 10043, Italy

  • CHU Nantes

    Saint-Herblain, 44800, France

  • CHU toulouse - hôpital Larrey

    Toulouse, 31059, France

  • Centre Leon Berard

    Lyon, 69008, France

  • Chang Gung Memorial Hospital CGMH - LinKou Branch

    Taoyuan, 333, Taiwan

  • Chung Shan Medical University Hospital

    Taichung, 40705, Taiwan

  • Chungbuk National University Hospital

    Taebuk, 28644, South Korea

  • Clinica Univ. de Navarra - P

    Pamplona, 31008, Spain

  • Clinica Universidad de Navarra

    Madrid, 28027, Spain

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, 02215, United States

  • Erasmus MC

    Rotterdam, 3015 GD, Netherlands

  • Gustav Roussy

    Villejuif, 94800, France

  • H. Lee Moffitt Cancer Center & Research Institute

    Tampa, Florida, 33612, United States

  • Henry Ford Cancer Institute/Henry Ford Hospital

    Detroit, Michigan, 48202, United States

  • Hopital Pontchaillou

    Rennes, 35000, France

  • Hospital 12 de Octubre

    Madrid, 28041, Spain

  • Hospital Universitari i Politècnic La Fe

    Valencia, 46026, Spain

  • Hospital Universitario Fundacion Jimenez Diaz

    Madrid, 28040, Spain

  • Hospital Universitario Vall d'Hebron

    Barcelona, 08023, Spain

  • Humanitas Cancer Center Istituto Clinico Humanitas

    Rozzano, 20089, Italy

  • IRCCS Istituto Europeo di Oncologia

    Milan, 20141, Italy

  • Istituto Nazionale Tumori Fondazione G. Pascale di Napoli Strutturadi Oncologia

    Naples, 80131, Italy

  • Kindai University Hospital

    Ōsaka-sayama, 589-8511, Japan

  • Massachusetts General Hospital (MGH) - Hematology/Oncology

    Boston, Massachusetts, 02114, United States

  • National Cancer Center Hospital East

    Kashiwa, 277-0882, Japan

  • National Cancer Central Hospital

    Chūōku, 104-0045, Japan

  • National Cheng Kung University Hospital NCKUH

    Tainan, 704, Taiwan

  • National Hospital Organization Kyushu Cancer Center

    Fukuoka, 11111, Japan

  • National Taiwan University Hospital

    Taipei, 10002, Taiwan

  • Netherlands Cancer Institute

    Amsterdam, 1066CX, Netherlands

  • Norton Cancer Institute

    Louisville, Kentucky, 40241, United States

  • Okayama University Hospital

    Okayama, 700-8558, Japan

  • Ospedale San Luca

    Lucca, 55100, Italy

  • Princess Alexandra Hospital

    Woolloongabba, 4102, Australia

  • SC Oncologia, AOU Policlinico Modena

    Modena, 41124, Italy

  • Samsung Medical Center

    Seoul, 6351, South Korea

  • Sarah Cannon Research Institute

    Nashville, Tennessee, 37203, United States

  • Seoul National University Bundang Hospital

    Seongnam, 463-707, South Korea

  • Seoul National University Hospital

    Seoul, 03080, South Korea

  • St John of God Subiaco Hospital

    Subiaco, 6008, Australia

  • Taichung Veterans General Hospital

    Taichung, 40705, Taiwan

  • University Health Network

    Toronto, M5G0A3, Canada

  • University of Colorado Denver - Anschutz Medical Campus

    Aurora, Colorado, 80045, United States

  • University of Michigan

    Detroit, Michigan, 48202, United States

  • Virgina Cancer Specialists

    Fairfax, Virginia, 22031, United States

  • Washington University School of Medicine

    St Louis, Missouri, 63110, United States